Navigation Links
NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
Date:5/28/2008

SOPHIA ANTIPOLIS, France, May 28 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced the completion of patient enrollment in the third pivotal phase 3 clinical trial for naproxcinod, in patients with osteoarthritis of the hip (the 303 study). 810 patients have been randomized in 120 clinical centers in North America and Europe in this study, which is the final phase 3 trial in NicOx' clinical plan for the regulatory filing of naproxcinod. The objective of this study is to assess naproxcinod's efficacy in relieving the signs and symptoms of osteoarthritis of the hip and provide additional safety data, including further information on naproxcinod's blood pressure profile in comparison to another anti-inflammatory medication. Results from this study are expected in Q4 2008 and NicOx projects the filing of a New Drug Application (NDA) in mid-2009.

NicOx is currently in the final stages of developing naproxcinod as an investigational drug for treating the signs and symptoms of osteoarthritis. Naproxcinod is the most advanced compound in a novel class of anti-inflammatory agents known as the Cyclooxygenase-Inhibiting Nitric Oxide Donators (CINODs). The 303 study follows the previous two pivotal phase 3 trials. Successful results were obtained in the 301 phase 3 study, in patients with osteoarthritis of the knee (see press release of October 27, 2006). These data demonstrated superior efficacy to placebo. Data collected suggested that naproxcinod could have no detrimental effect on blood pressure, in contrast to naproxen, a widely used non-steroidal anti-inflammatory drug (NSAID). NSAIDs are known to have the tendency to elevate blood pressure to an extent that may increase the rate of serious cardiovascular adverse events, such as heart attack and stroke.

The 302 study for naproxcinod in patients with osteoarthritis of the knee (see press release of April 3, 2007) is due to report results in Q3 2008.

Maarten Beekman, Vice
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
2. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
3. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
4. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
5. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
6. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
7. NicOx Naproxcinod ABPM Data Presented at American Heart Association
8. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
9. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
10. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
11. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 04, 2015 ... has announced the addition of the "MRI ... Comfort and Operational Efficiency, with Growth Driven by ... "MRI Systems Market to 2020 - Focus ... Driven by Developing Economies" discusses the market, competitive ...
(Date:8/4/2015)... 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... $18.9 million for the three and six months ended ... of $12.1 million and $43.4 million for the same ... driven primarily by the more than $90 million of ... the upfront payment from Bayer to license  ISIS-FXI Rx ...
(Date:8/4/2015)... DUBLIN , Aug. 4, 2015 /PRNewswire/ ... announced the addition of Jain PharmaBiotech,s new ... Markets, and Companies" to their offering. ... transdermal drug delivery - an approach used ... therapeutic use as an alternative to oral,intravascular, ...
Breaking Medicine Technology:Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... How Each Tooth Signals the Next to Start GrowingROCHESTER, ... forces determines why mammals develop a single row of ... published today in the journal Science. When completely understood, ... guide efforts to re-grow missing teeth and prevent cleft ...
... preventing bone loss focus on early screening and treatmentLAS ... 75 million baby boomers are approaching the age where ... Osteoporosis ( http://orthoinfo.aaos.org/topic.cfm?topic=A00232 ) also contributes ... United States annually. According to new information presented ...
Cached Medicine Technology:Scientists Discover Why Teeth Form in a Single Row 2Scientists Discover Why Teeth Form in a Single Row 3Scientists Discover Why Teeth Form in a Single Row 4Scientists Discover Why Teeth Form in a Single Row 5Staying One Step Ahead of Osteoporosis 2Staying One Step Ahead of Osteoporosis 3Staying One Step Ahead of Osteoporosis 4
(Date:8/4/2015)... ... August 04, 2015 , ... ... product packaging, and fulfillment services, joined over 200 other Long Island-based corporations as ... on Tuesday, July 28th at Jones Beach State Park in Wantagh, New York. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are invited to ... the world renowned Beverly Hills facelift surgeon , Dr. Paul Nassif. The ... helps individuals to achieve an outer appearance that meets their personal goals. This ...
(Date:8/4/2015)... ... August 04, 2015 , ... Montclair State University and Atlantic Health System have ... kind in New Jersey, which starting this Fall will help prepare those entering this ... with Atlantic Health System, one of the largest health care organizations in New Jersey, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... nursing homes and other long-term care facilities, today announced details of the Advanced ... nursing homes and centers. , Providigm’s QAPI Accreditation program , introduced in ...
(Date:8/4/2015)... Vegas, Nevada (PRWEB) , ... August 04, 2015 ... ... FEMALE, a striking contemporary look at unique artistic expressions from a diverse group ... inside the Life Is Beautiful Music & Art Festival on September 25-27, 2015 ...
Breaking Medicine News(10 mins):Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4
... arrest patients treated with hypothermia may be withdrawn too soon ... awakening that,s not apparent for a week several days ... researchers said. For more than 25 years, the prognosis ... care has been based on a neurological exam at 72 ...
... HealthDay Reporter , FRIDAY, Nov. 12 (HealthDay ... as "stroke centers of excellence" or "chest pain centers," ... stroke and heart attacks. But current programs for ... best cardiovascular or stroke care are falling short, according ...
... , FRIDAY, Nov. 12 (HealthDay News) -- Talking to ... once they,re in school, researchers say. Children whose parents ... the cardinal number principle -- the size of a set ... counting the set, the University of Chicago researchers found. ...
... missed a "Mac" in 28 years. At 44, he,s one ... receive the designation of "goat" once they,ve completed 20 or ... Mich. Armstrong has sailed the race every year since he ... July. Instead, he was in intensive care awaiting heart transplant ...
... spend about a third of our lives asleep. So there ... that sleep helps consolidate memories, fixing them in the brain ... showing that sleep also seems to reorganize memories, picking out ... produce new and creative ideas, according to the authors of ...
... Research Center, Emory University, will present a wide range ... annual meeting in San Diego, Nov. 13-17, 2010. The ... Yerkes scientists will be discussing. To learn more about ... Research Center and the other seven national primate research ...
Cached Medicine News:Health News:Saturday news tips: Resuscitation Science Symposium 2Health News:Saturday news tips: Resuscitation Science Symposium 3Health News:Saturday news tips: Resuscitation Science Symposium 4Health News:Saturday news tips: Resuscitation Science Symposium 5Health News:Setting National Hospital Standards Could Boost Cardiac Care 2Health News:Setting National Hospital Standards Could Boost Cardiac Care 3Health News:Myocarditis can attack hearts without warning 2Health News:Sleep makes your memories stronger 2Health News:Yerkes researchers present at 40th Annual Society for Neuroscience Conference 2Health News:Yerkes researchers present at 40th Annual Society for Neuroscience Conference 3Health News:Yerkes researchers present at 40th Annual Society for Neuroscience Conference 4Health News:Yerkes researchers present at 40th Annual Society for Neuroscience Conference 5
Algerbrush II corneal rust ring remover battery powered...
Katena ophthalmic burr for polishing pterygiums, includes one round diamond burr and has an storage case....
... TW full diameter trial lens set has ... twenty years. While maintaining only the highest ... the Marco 35-6 TW trial lens set ... by adhering to strict industry guidelines, and ...
Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted...
Medicine Products: